The ETHZilla plan for equity financing has increased to $10 billion, which will support the continued purchase of ETH.

According to news from HashChain, Strategic ETH Reserve announced on platform X that the Nasdaq-listed Ethereum treasury company ETHZilla (formerly 180 Life Sciences Corp.) has disclosed the revision of the previously signed securities sales agreement, which involves supplementary documents to the prospectus and accompanying prospectuses for the issuance of common stock. According to the terms of the revised sales agreement, the company will be able to raise up to $1 billion through the issuance and sale of common stock to support its continued purchase of ETH.